课题基金 / 基金详情

ANTISENSE OLIGONUCLEOTIDES AS INHIBITORS OF TUMOR-INDUCED ANGIOGENESIS

ANTISENSE OLIGONUCLEOTIDES AS INHIBITORS OF TUMOR-INDUCED ANGIOGENESIS
反义寡核苷酸作为肿瘤诱导的血管生成的抑制剂
批准号:
2463693
负责人:
J A LAUTENBERGER
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

J A LAUTENBERGER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have investigated the role of one ets family member, ETS1, in the angiogenesis. Vascular endothelial growth factor (VEGF) increases the level of ETS1 mRNA and protein levels in human umbilical vein endothelial cells (HUVEC). VEGF was also found to stimulate the ability of HUVEC to migrate through Matrigel or gelatin coated membranes. This VEGF-induced invasiveness was inhibited by antisense ETS1 oligonucleotides but not by a sense or mismatch controls. Together, these observations demonstrate a direct role for the ETS1 gene in angiogenesis. We have established immortalized HUVEC by the HPV-16 E6-E7 genes and further transformed one immortalized but nontumorigenic line (4-5-2G) by v-Ki-ras to produce tumorigenic cell lines. E6 or E7 alone could not produce immortalized lines but extended the life span of the cells. 4-5-2G had a cobblestone morphology that developed into a capillary-like tube structure upon reaching confluence. It expressed factor VIII, took up DiI-Ac-LDL, and expressed integrin subunits in a pattern consistent with an endothelial origin. These results indicate that 4-5-2G may serve as a model for endothelial cell biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ANALYSIS OF HIV MESSENGER RNA STRUCTURE
IDENTIFICATION OF MOLECULAR MARKERS FOR HUMAN LUNG CANCER
ANTISENSE OLIGONUCLEOTIDES AS INHIBITORS OF TUMOR-INDUCED ANGIOGENESIS
STRUCTURAL, BIOCHEMICAL, AND BIOLOGICAL CHARACTERIZATION OF HIV NEF AND VPU
海外基金